PrevengHo-Vir®, pharmacovigilance study in five communities of Santa Clara

Authors

Keywords:

homeopathy, adverse reaction, treatment

Abstract

Introduction: in the face of the health emergency, Cuban science undertook a series of protocols with the aim of achieving an effective treatment against COVID-19, thus giving rise to a homeopathic preparation called PrevengHo®-Vir. The trial has not yet finished and there remains a gap of doubts regarding the possible adverse reactions that the preparation could cause. Objective: to characterize clinically and epidemiologically five towns´ populations that consumed the homeopathic preparation and to identify the main adverse reactions reported by the patients under study. Method: an observational, descriptive, cross-sectional study was carried out in five towns in the municipality of Santa Clara, with the total of patients who used the preparation; with the sample being N=505. Results: a ratio of men and women of 1:1 is presented, with an average of 44.3 years of age, 63.7% have a high school degree (above 12th grade), only 4.8% used the preparation incorrectly, of which 3.2% had a low educational level. A total of 13 subjects presented reactions. Conclusions: Most of the adverse reactions are mild and do not require urgent medical attention. The homeopathic preparation PrevengHo®-Vir is safe and without risk to the lives of consumers.

Downloads

Download data is not yet available.

References

Báez Pérez OL, Díaz Domínguez TC, Márquez Marrero JL, Acosta Morales ML. Regularidades del proceso formativo en Medicina Tradicional y Natural. Carrera de Medicina. Pinar del Río. Rev Cienc Méd Pinar del Río [Internet]. 2013 [citado 15 Oct 2020]; 17(2): [aproximadamente 9 p.]. Disponible en: http://www.revcmpinar.sld.cu/index.php/publicaciones/article/view/1251

López González I, Pérez González M, Artiles López L. La Homeopatía como modalidad terapéutica en América: Un encuentro histórico necesario. EDUMECENTRO [Internet]. 2015 [citado 15 Oct 2020]; 8(1):76-77. Disponible en: http://www.revedumecentro.sld.cu

Ullman D. Evidencia científica para la medicina homeopática. homeop Méx [Internet]. 2017 [01 Abr 2022]; 86(711):5-18. Disponible en: https://docs.bvsalud.org/biblioref/2018/03/880085/evidencia-cientifica-para-la-medicina-homeopatica.pdf

Echegaray Rodríguez JR, Echegaray González P, Mosquera Fernández A, Gerrikaetxebarria Peña J. Homeopatía. Principales remedios homeopáticos. Rev Esp Pedol [Internet]. 2011 [1 Abr 2022]. 22(6): 226-233. Disponible en: https://www.revesppod.com/homeopatia-principales-remedios-homeopaticos306?AspxAutoDetectCookieSupport=1

Álvarez González JL. Homeopatía: Una ilusión más allá del número de Avogadro. Rev Cubana Física [Internet]. 2008 [octubre 2020]; 25(1):38-44. Disponible en: www.fisica.uh.cu/biblioteca/revcubfi/index.htm

Dominguez AN, Valdéz A. COVID-19. Punto de vista del cardiólogo. Rev Cubana Card Cir Cardiov [Internet]. 2020 [citado 1 Abr 2022]; 26(1):951. Disponible en: http://revcardiologia.sld.cu/index.php/revcardiologia/article/download/951/pdf

Parra-Izquierdo V, Flórez-Sarmiento C, García del Risco F, Romero-Sánchez C. Síntomas gastrointestinales en la enfermedad por COVID-19 y sus implicaciones en la Enfermedad Inflamatoria Intestinal. Rev Colomb Gastroenterol [Internet]. 2020 [citado 1 Abr 2022]; 35:45-55. Disponible en: http://www.scielo.org.co/pdf/rcg/v35s1/0120-9957-rcg-35-s1-00045.pdf

Prevengho-Vir. rpcec.sld.cu. La Habana: RPCEC; 2020 [Citado 5 Ago 2021] Disponible en: https://rpcec.sld.cu/ensayos/RPCEC00000312-Sp

Prevengho-Vir. Nota informativa del CECMED. www.cecmed.cu. La Habana; 2020 Abr. [citado 1 Abr 2022]. Disponible en: https://www.cecmed.cu/noticias/nota-informativa-cecmed-prevengho-vir

MINSAP. Regulación No 53-2011. Requisitos para el registro de medicamentos homeopaticos de uso humano [Internet]. La Habana: CECMED; 2011. [citado 1 Abr 2022]. Disponible en: https://www.cecmed.cu/sites/default/files/adjuntos/Reglamentacion/Reg_53-11.pdf#overlay-context=reglamentacion/aprobadas%3Fpage%3D8

MINSAP. Regulación No. 58-2011. Buenas prácticas de fabricación de medicamentos homeopáticos [Internet]. La Habana: CECMED; 2011. [Citado 1 Abr 2022]. Disponible en: https://www.cecmed.cu/sites/default/files/adjuntos/Reglamentacion/reg_58-11.pdf

Prevengho-Vir. www.cecmed.cu. La Habana; 2020 [citado 5 Ago 2021]. Disponible en: https://www.cecmed.cu/registro/rcp/prevenghor-vir

Derrick E. Aarons. Explorando el balance riesgos/beneficios en la investigación biomédica: algunas consideraciones. Rev Bioét [Internet]. 2017 [citado 1 Abr 2022]; 25(2):320-7. Doi: http://dx.doi.org/10.1590/1983-80422017252192

Casas Gálvez I. Uso de medicación homeopática y medicina biorreguladora: conocimiento del paciente [Tesis doctorado]. Madrid: Universidad Complutense de Madrid; 2015. Disponible en: https://eprints.ucm.es/id/eprint/29714/1/T35993.pdf

Moffet JR, Arun P, Namboodiri MAA. La-boratory research in homoeopathy: Con. Integr. CancerTher. 2006; 5:333-342.

Rawlins M, Thomson W. Mechanisms of adverse drug reactions. Davies D. Textbook of adverse drug reactions. New York: Oxford University Press; 1991.

Dantas F, Rampes H. Do homeopathic medicines provoke adverse effects? A systematic review. Brit Homeop J. 2000; 89(Suppl 1):S35-S38.

Posadzki P, Alotaibi A, Ernst E. Adverse Effects of Homeopathy. A Systematic Review of Published Case Reports and Case Series. Int J Clin Pract. 2012; 66(12):1178-1188.

Bishop JL, Northstone K, Green JR, Thompson EA. The use of Complementary and Alternative Medicine in pregancy: data from the Avon Longitudinal Study of Parents and Children (ALSPAC). Complem Ther Med. 2011; 19(6): 303-10.

Fisher P. Aims and priorities for research in complementary medicine: a proposal for an adverse effect reporting scheme. Complem Med Res. 1987 Feb. 2(1).

Fisher P, Dantas F, Rampes H. The safety of homeopathic products. J R Soc Med. 2002; 95(9):474-476.

Pomposelli R, Codecá G, Bergonzini R, et al. Terapia omeopatica in pazienti con patologia artroreumatica. Med Nat (Milano). 2003; 13(6):44-50.

Rossi E, Crudeli L, Garibaldi D. Valutazione delle variazioni del consumo farmacologico convenzionale e dei costi economici in corso di terapia omeopatica classica in pazienti affetti da disturbi delle vie respiratorie. Proceedings of the International Conference Safety evaluation of complementary and alternative medicine, Palazzo delle Esposizioni, Empoli 24-25 October, 2003. Palazzo delle Esposizioni; 2003 Oct. p.23. Disponible en: https://jorcienciainhem2021.sld.cu/index.php/jorcienciainhem/2021/paper/downloadSuppFile/8/6

Endrizzi C, Rossi E, Crudeli L and Garibaldi D. Harm in homeopathy: Aggravations, adverse drug or medication errors? Homeopathy. 2005; 233-240.

Published

2022-03-16

How to Cite

1.
Campos-Sánchez CM, Guillén-León LA, Acosta-Escanaverino I, Rodríguez-Hurtado D, Gómez-Saucedo ML. PrevengHo-Vir®, pharmacovigilance study in five communities of Santa Clara. Gac méd estud [Internet]. 2022 Mar. 16 [cited 2024 May 15];3(1):e181. Available from: https://revgacetaestudiantil.sld.cu/index.php/gme/article/view/59

Issue

Section

Original articles

Similar Articles

You may also start an advanced similarity search for this article.